Упрощенная HTML-версия
126.
Chisari F.V. Viruses, immunity and cancer: Lessons from hepatitis B / F.V.
Chisari // Am. J. Pathol. - 2000. - Vol.
154. - P.
1118-1132.
127.
Circulating IL-2 and IL-10 in chronic active hepatitis C with respect to the
response to IFN treatment / H. Bozkaya, A.M. Bozdayi, N. Aslan et al. //
Infection. - 2000. -Vol.28,№5. - Р. 309-313.
128.
Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to
HBeAg status and the activity of liver disease / H. Bozkaya, M. Bozdayi, R.
Turkyilmaz et al. // Hepatogastroenterology. - 2000. - Vol.47,№36. - Р. 1675-
1679.
129.
Circulating Th1 and Th2 cytokines in patients with hepatitis C virus infection /
X.G. Fan, W.E. Liu, C.Z. et al. // Mediators. Inflamm. - 1998. - Vol.7,№4. - Р.
295-297.
130.
Clinical and epidemiological features of patients with clonorchiasis / K.X.
Wang, R.B. Zhang, Y.B. Cui et al. // World. J. Gastroenterol. - 2004. - Vol.10,№3.
-Р. 446-448.
131.
Comparative analysis of HLA restriction and cytokine production in hepatitis
B surface antigen-specific T cells from low- and high-antibody responders in
vaccinated humans / M. Wataya, T. Sano, N. Kamikawaji et al. // J. Hum. Genet.-
2001. - Vol.46,№4. - Р. 197-206.
132.
Concordant type 1
cytokine
mRNA and prote
in
expression
in
chronic HCV-
in
fected livers is associated with the transcription of the novel IFN-
in
duc
in
g factor
(IL-18) gene / A.S. Gaweco, V.K. Rustgi, B. Mitchell et al. // Hepatology. - 1997.-
Vol.26. - P. 409.
133.
Cutting edge: Inhibition of hepatitis B virus replication by activated NK T cells
does not require inflammatory cell recruitment to the liver / K. Kakimi, T.E. Lane,
F.V. Chisari, L.G. Guidotti // J. Immunol. - 2001. - Vol.
167. - P.
6701-6705.